IPSOF moved above its 50-day moving average on December 10, 2024 date and that indicates a change from a downward trend to an upward trend. In of 6 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The 10-day moving average for IPSOF crossed bullishly above the 50-day moving average on December 10, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 6 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.614) is normal, around the industry mean (27.597). P/E Ratio (11.547) is within average values for comparable stocks, (88.791). IPSOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.729). Dividend Yield (0.025) settles around the average of (0.038) among similar stocks. P/S Ratio (1.033) is also within normal values, averaging (11.883).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IPSOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry MiscellaneousCommercialServices
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RTSSX | 43.50 | 0.30 | +0.69% |
Russell Inv Tax-Managed US Mid&Sm Cap S | |||
MITCX | 36.87 | -0.98 | -2.59% |
MFS Massachusetts Investors Tr C | |||
TCVIX | 22.82 | -0.69 | -2.93% |
Touchstone Mid Cap Value Inst | |||
NQCRX | 4.93 | -0.15 | -2.95% |
Nuveen Large Cap Value Opportunities I | |||
ETEGX | 15.43 | -0.58 | -3.62% |
Eaton Vance Small-Cap A |
A.I.dvisor tells us that IPSOF and BRC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSOF and BRC's prices will move in lockstep.
Ticker / NAME | Correlation To IPSOF | 1D Price Change % | ||
---|---|---|---|---|
IPSOF | 100% | N/A | ||
BRC - IPSOF | 24% Poorly correlated | -2.84% | ||
IVDA - IPSOF | 6% Poorly correlated | -9.17% | ||
KMNCF - IPSOF | 0% Poorly correlated | N/A | ||
KBRLF - IPSOF | -0% Poorly correlated | -3.41% | ||
IKTSY - IPSOF | -2% Poorly correlated | +1.14% | ||
More |